| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7863763 | Journal of Controlled Release | 2015 | 20 Pages |
Keywords
EGFRN-(2-Hydroxypropyl) methacrylamidesomatostatin receptor 2AMLFDAHPMACancer nanomedicinePLGA-PEGNaBRESGMPSSTHSAEMAEGFADCClinical trialshuman serum albuminEuropean Medicines agencyUS Food and Drug AdministrationImmunoliposomeDrug deliveryEPRGood Manufacturing PracticeWorld Health Organizationreticulo-endothelial Systemepidermal growth factoracute lymphoid leukemiaacute myeloid leukemiaLiposomeNanoparticleEnhanced permeability and retention effectTargetingALLpolyethylene glycolPolydispersityPEGAntibody drug conjugateWHOEpidermal growth factor receptor
Related Topics
Physical Sciences and Engineering
Materials Science
Biomaterials
Authors
Andreas Wicki, Dominik Witzigmann, Vimalkumar Balasubramanian, Jörg Huwyler,